The new World Health Organization classification of lymphomas: The past, the present and the future (Reprinted from the Intenal Medicine, vol 86, pg 434-443, 2000)

被引:88
作者
Chan, JKC [1 ]
机构
[1] Queen Elizabeth Hosp, Dept Pathol, Kowloon, Hong Kong, Peoples R China
关键词
lymphoma; classification; REAL classification; WHO classification; Hodgkin's lymphoma; immunohistochemistry; molecular genetics;
D O I
10.1002/hon.660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The REAL Classification of lymphomas, proposed in 1994. represents a new paradigm in lymphoma classification, consisting of a list of biologic entities defined by clinicopathologic and immunogenetic features. The non-Hodgkin's lymphomas comprise precursor lymphoblastic and mature cell neoplasms of B, T or putative natural killer cell lineage. An individual entity can exhibit a range of morphologic appearances and a range of clinical behavior. The categories in Hodgkin's lymphomas are identical to the widely used Rye classification except for the additional of a new category termed 'lymphocyte-rich classical Hodgkin's lymphoma'. The REAL classification has been validated by a major multi-institutional study involving 1378 cases (The Non-Hodgkin's Lymphoma Classification Project), showing that it is both reproducible and clinically relevant. The new World Health Organization classification of hematopoietic and lymphoid tumors. to be published in 200 1, is a joint project of the Society for Hematopathology and European Association of Hematopathologists, under the auspices of the World Health Organization. This classification includes not only lymphoid neoplasms. but also myeloid, histiocytic and mast cell neoplasms. The lymphoma component of the classification is merely an update of the REAL classification. with minor changes necessitated by new information that has become available since its proposal. A conceptual grouping of the non-Hodgkin's lymphomas into four categories (indolent, aggressive, highly aggressive, and localized indolent) is also presented in this review. The next major impetus influencing the approach to lymphoma classification will no doubt be molecular genetics, in particular DNA microarrays, which will yield an enormous amount of new data that will aid in the understanding of lymphomas. Copyright (C) 2001 John Wiley Sons, Ltd.
引用
收藏
页码:129 / 150
页数:22
相关论文
共 77 条
[31]  
Falini B, 1999, BLOOD, V94, P3509
[32]   A CLINICAL ANALYSIS OF 2 INDOLENT LYMPHOMA ENTITIES - MANTLE CELL LYMPHOMA AND MARGINAL ZONE LYMPHOMA (INCLUDING THE MUCOSA-ASSOCIATED LYMPHOID-TISSUE AND MONOCYTOID B-CELL SUBCATEGORIES) - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].
FISHER, RI ;
DAHLBERG, S ;
NATHWANI, BN ;
BANKS, PM ;
MILLER, TP ;
GROGAN, TM .
BLOOD, 1995, 85 (04) :1075-1082
[33]   How DNA microarrays and expression profiling will affect clinical practice [J].
Friend, SH .
BRITISH MEDICAL JOURNAL, 1999, 319 (7220) :1306-U77
[34]   Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma [J].
Gascoyne, RD ;
Aoun, P ;
Wu, D ;
Chhanabhai, M ;
Skinnider, BF ;
Greiner, TC ;
Morris, SW ;
Connors, JM ;
Vose, JM ;
Viswanatha, DS ;
Coldman, A ;
Weisenburger, DD .
BLOOD, 1999, 93 (11) :3913-3921
[35]   PULMONARY LYMPHOMATOID GRANULOMATOSIS - EVIDENCE FOR A PROLIFERATION OF EPSTEIN-BARR-VIRUS INFECTED B-LYMPHOCYTES WITH A PROMINENT T-CELL COMPONENT AND VASCULITIS [J].
GUINEE, D ;
JAFFE, E ;
KINGMA, D ;
FISHBACK, N ;
WALLBERG, K ;
KRISHNAN, J ;
FRIZZERA, G ;
TRAVIS, W ;
KOSS, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (08) :753-764
[36]   Proliferation and cellular phenotype in lymphomatoid granulomatosis [J].
Guinee, DG ;
Perkins, SL ;
Travis, WD ;
Holden, JA ;
Tripp, SR ;
Koss, MN .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (09) :1093-1100
[37]   Mutational analysis using oligonucleotide microarrays [J].
Hacia, JG ;
Collins, FS .
JOURNAL OF MEDICAL GENETICS, 1999, 36 (10) :730-736
[38]  
Harris N. L., 2000, Histopathology (Oxford), V36, P69
[39]   The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
MODERN PATHOLOGY, 2000, 13 (02) :193-207
[40]   The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
ANNALS OF ONCOLOGY, 1999, 10 (12) :1419-1432